Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively. Investment will expand product
Studies as a service
Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks
Explore our solutions
PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.
PhysioMimix Core
